María Luisa García

Investigadora principal y responsable de instalaciones




Since the beginning of my scientific career I have worked in the field of Magnetic Resonance applied to biomedical research. I did my PhD at the "Alberto Sols" Biomedical Research Institute (CSIC/UAM). During this period, I complemented my training with short stays in several institutions, both in Europe and in the United States. After my PhD, I joined the University of Arizona’s Cancer Center as a Research Associate, where I developed my scientific activity for the next three years, until I returned to the Biomedical Research Institute in Madrid as a "Ramón y Cajal" researcher. During this period, my work focused on the characterization of the tumor microenvironment using multiparametric magnetic resonace imaging and spectroscopy. In 2008 undertook a position as Clinical Scientist at the "María Rafols Foundation for the Investigation of Diagnostic Imaging" in Madrid, where I worked on the implementation of advanced MRI techniques for the early detection of cancer. Finally, in 2011, I joined the Andalusian Center for Nanomedicine and Biotechnology (BIONAND) in Málaga, as Group Leader of the Biomedical Magnetic Resonance Lab, within the area of Nanodiagnostics, and also as head of the NanoImaging Unit, a multimodal imaging platform that has been recently accredited as part of the NANBIOSIS-ICTS (Singular Scientific and Technological Infrastructure). In addition, from 2014 to 2019 I also held the position of Scientific Deputy Director. My research is focused on two main topics: i) development of multifunctional magnetic nanomaterials for magnetic resonance molecular imaging (mMRI) and targeted tumor therapy; ii) NMR-based metabolomics of biofluids and tissue biopsies for the identification of diagnostic, prognostic and treatment response biomarkers, of several diseases, mainly cancer and neurodegenerative diseases. I have participated in 19 publiclyfunded research projects and led 7 of them. I review papers for several scientific journals (Nanoscale, Contrast Media and Molecular Imaging, Biomaterials, etc.) and belong to the editorial board of "Contrast Media and Molecular Imaging" and "Frontiers in Oncology". I have authored 56 publications, 37 of which are in Q1. I have also edited the book "Preclinical MRI: methods and protocols” for the series "Methods in Molecular Biology", by Springer Nature. As corresponding author, it is worth mentioning publications in high impact journals, such as Cancer Research, Nanoscale, Biomacromolecules, and also publications in recognized journals in the area biomedical magnetic resonance, such as NMR in Biomedicine and Magnetic Resonance in Medicine.